Previous Page  46 / 51 Next Page
Information
Show Menu
Previous Page 46 / 51 Next Page
Page Background

Immunology 2018

J u l y 0 5 - 0 7 , 2 0 1 8

V i e n n a , A u s t r i a

Page 109

Journal of Clinical Immunology and Allergy

ISSN 2471-304X

1 5

t h

I n t e r n a t i o n a l C o n f e r e n c e o n

Immunology

Background:

Monocytes are important effector cells during

Leishmania

infection and changes in their functions may impact

development of immunity. However, functional characteristics of monocytes in visceral leishmaniasis (VL) patients remains

poorly understood.

Methods:

Peripheral blood monocytes from VL patients and healthy endemic controls (ECs) from Muzaffarpur, Bihar, India were

isolated and compared

ex-vivo

using cell-culture techniques, flow cytometry and RT-qPCR.

Results:

A blood monocyte population with a gene signature comprising upregulated expression of

TGM2, CTLRs, VDR, PKM,

SOCS1, CAMP1

, accompanied by downregulated expression of

NOS2

and

HIF1A

was observed in VL patients, compared to ECs. VL

patient monocytes also had impaired expression of chemokine receptors, adhesion molecules and decreased frequencies of IL-

1β- and IL-6-producing cells. Importantly, monocytes from VL patients had a marked reduction in their capacity for phagocytosis

of amastigotes, as well as expression of p47phox, p67phox and ROS-production.

Conclusions:

VL monocytes express anti-inflammatory molecules and lack a classically activated phenotype. They have reduced

expression of molecules related to activation and anti-parasitic effector functions, indicating that monocytes are skewed towards

anti-inflammatory phenotype. These findings provide insights into functional status of monocytes during VL and advise that

therapeutic manipulation of this important cell population may result in favourable patient outcomes

neetu24sep@gmail.com

Peripheral blood monocytes with an anti-

inflammatory phenotype display limited

phagocytosis and oxidative burst in visceral

leishmaniasis patients

Neetu Singh

1

, Rajiv Kumar

2

, Shashi Bhushan Chauhan

1

, Christian

Engwerda

3

and Shyam Sundar

1

1

Institute of Medical Sciences, Banaras Hindu University, India

2

Banaras Hindu University, India

3

QIMR Berghofer Medical Research Institute, Australia

Insights Allergy Asthma Bronchitis 2018, Volume: 4

DOI: 10.21767/2471-304X-C1-003